本报讯 （记者向炎涛）日前，中国建筑股份有限公司（以下简称"中国建筑"）发布2025年第一季度报 告，公司各项核心经营数据亮眼。报告期内，公司实现新签合同额12702亿元，同比增长6.9%；实现营 业收入5553亿元，同比增长1.1%；实现归属于上市公司股东的净利润150.1亿元，同比增长0.6%。 公司控股股东中国建筑集团有限公司（以下简称"中建集团"）基于对公司未来发展前景的信心及中长期 投资价值的认可，持续对公司进行增持。截至2025年4月8日，中建集团已累计增持公司1.1亿股A股股 份，占公司总股本比例约为0.27%，对应增持总金额约6.1亿元（不含税费）。 同时，中国建筑披露了《关于"提质增效重回报"行动方案执行情况的评估报告》，展示了公司在提高发 展质量、增强回报投资者能力等方面的高效落实情况。 基于中国建筑第一季度业绩的稳健增长，多家券商机构给予积极评价。其中，天风证券研究报告显示， 从中长期看公司作为建筑领域龙头央企，市占率有望逐步提升，建议关注公司中长期投资价值，维 持"买入"评级。 （文章来源：证券日报） 地产业务方面，报告期内公司新增土地储备195万平方米，全部位于一线、强二线及省会城市 ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 旺能环境(002034) 投资评级 —— 上次评级 —— [Table_Author] 郭雪 执业编号：S1500525030002 邮 箱： XXXXX xxx 行业分析师 左前明 能源行业首席分析师 执业编号：S1500518070001 联系电话：010-83326712 邮 箱：zuoqianming@cindasc.com [Table_Author 郭雪 环保联席首席分析师 执业编号：S1500525030002 邮 箱：guoxue @cindasc.com 吴柏莹 环保行业分析师 执业编号：S1500524100001 邮 箱：wuboying@cindasc.com 请阅读最后一页免责声明及信息披露 http://www.cindasc.com 1 化工行业： [Table_OtherReport] 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 [Table_Title] 计提减值 ...

Group 1 - The 2025 "Hui" Night Guangxi Service Consumption Season event has been launched in Nanning, focusing on enhancing service consumption and improving the quality of life for residents [1] - The event will run from late April to June, featuring over 300 night-time promotional activities across seven themes: night food, night shopping, night accommodation, night tourism, night fitness, night performances, and night entertainment [1] - A new mini-program called "Fireworks Night Guangxi" has been launched, showcasing 100 featured commercial streets across 14 cities, providing a comprehensive guide for consumers on shopping, dining, and accommodation [1] Group 2 - The Guangxi Commerce Department will distribute consumer vouchers for supermarkets and dining accommodations during the event, alongside hosting over 20 promotional activities related to product exchanges and foreign trade products transitioning to domestic sales [2] - The event includes various themed areas such as an exhibition area for foreign trade products, a trade-in zone for home appliances and electric bicycles, and a creative market for pet cafes, enhancing the night-time consumption experience [1]

Investment Rating - The investment rating for 旺能环境 (002034) is not explicitly stated in the report [1]. Core Insights - The report highlights that the company's performance is under short-term pressure due to impairment provisions, while the operational efficiency of waste incineration is continuously improving [1][3]. - In 2024, the company achieved total revenue of 3.173 billion yuan, a slight decrease of 0.17% year-on-year, and a net profit attributable to shareholders of 561 million yuan, down 6.9% year-on-year [1][3]. - The first quarter of 2025 showed a positive trend with total revenue of 874 million yuan, an increase of 11.12% year-on-year, and a net profit of 201 million yuan, up 10.62% year-on-year [1][3]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of 3.173 billion yuan, a decrease of 0.17% from 2023, primarily due to a reduction in BOT project construction revenue [3]. - The net profit attributable to shareholders was 561 million yuan, a decline of 6.9%, influenced by increased bad debt provisions and asset disposal losses [3]. - The gross profit margin improved to 38.54%, up 1.2 percentage points year-on-year [3]. Business Segments - The main business segments generated the following revenues in 2024: - Municipal solid waste operations: 2.296 billion yuan (+3.5%) - Kitchen waste operations: 462 million yuan (+27.29%) - BOT project construction: 31 million yuan (-88.18%) - Rubber recycling: 187 million yuan (+81.45%) - Lithium battery recycling: 57 million yuan (-33.89%) [3]. - The gross profit margins for these segments were 47.89%, 31.33%, 0%, -5.64%, and -59.9%, respectively [3]. Operational Efficiency - As of the end of 2024, the company had 21 operational waste-to-energy plants with a total capacity of 21,820 tons, including the South Taihu Phase V project, which achieved a thermal efficiency increase from 22% to 30% [3]. - In Q1 2025, the waste incineration power generation projects generated revenue of 656 million yuan, a year-on-year increase of 7.52% [3]. Future Outlook - The company forecasts revenues of 3.359 billion yuan, 3.428 billion yuan, and 3.592 billion yuan for 2025, 2026, and 2027, respectively, with growth rates of 5.9%, 2.0%, and 4.8% [6]. - The net profit attributable to shareholders is expected to be 693 million yuan, 753 million yuan, and 795 million yuan for the same years, with growth rates of 23.5%, 8.7%, and 5.5% [6].

2025 年 5 月 3 日 公司研究 利润稳健增长，经营质量持续提升 ——徐工机械（000425.SZ）2024 年年报、2025 年一季报点评 要点 净利润稳健增长，净利率持续提升 徐工机械 24 年实现营业收入 916.6 亿元，同比下降 1.3%；归母净利润 59.8 亿元，同比增长 12.2%；经营性现金净流入 57.2 亿元，同比增长 60.2%。毛利 率为 22.5%，同比上升 0.2 个百分点；净利率为 6.5%，同比上升 0.9 个百分点。 公司 25Q1 实现营业收入 268.1 亿元，同比增长 10.9%；归母净利润 20.2 亿元，同比增长 26.4%；经营性现金净流入 8.3 亿元，同比增长 257.2%。毛利 率为 22.1%，同比下降 0.8 个百分点；净利率为 7.6%，同比上升 0.9 个百分点。 传统产业提质增效，新兴产业发展壮大 24 年公司起重机械收入 189.0 亿元，同比下降 10.8%；土方机械收入 240.1 亿元，同比增长 6.4%；混凝土机械收入 94.1 亿元，同比下降 9.8%；高空作业 机械收入 86.8 亿元，同比下降 2.3%；矿业机械收入 63. ...

Core Viewpoint - Junshi Bioscience reported a strong revenue growth of 31.46% year-on-year for Q1 2025, driven by its core product, Toripalimab, which achieved a sales revenue of 447 million yuan, reflecting a 45.72% increase year-on-year [2] Group 1: Financial Performance - The company achieved a total revenue of 500 million yuan in Q1 2025, with a net loss of 235 million yuan, which is a reduction in loss compared to the previous year [2] - Cash and cash equivalents, along with trading financial assets, totaled 3 billion yuan as of March 31, 2025 [2] - Sales expenses increased by 17.79% year-on-year to 226 million yuan, accounting for 45% of total revenue, a decrease of 5 percentage points from Q1 2024 [2] Group 2: Product Development and Regulatory Approvals - Toripalimab has received approval for 12 indications in China, with 10 included in the national medical insurance directory, four of which are exclusive indications [3] - The company has made progress in international expansion, with Toripalimab approved in multiple countries including the US, EU, and Australia, and has established commercial partnerships in over 80 countries [3] - Two early-stage pipelines, JS212 and JS213, have received clinical trial approvals from the National Medical Products Administration [3] Group 3: Future Catalysts - Key catalysts for 2025 include data readouts for Toripalimab combined with Lenvatinib for first-line HCC, early clinical data for JS107, and early clinical data for JS015 targeting gastrointestinal tumors [4] - The company plans to submit for market approval for JS005 for psoriasis treatment by the end of 2025 [4] Group 4: Investment Recommendation - The target market value is estimated at 47.4 billion yuan, corresponding to a target price of 48.10 yuan per share, maintaining a "buy" rating [5] - Recent analyst coverage indicates a consensus target price of 48.1 yuan, with two institutions giving a buy rating [7]

本届广交会取消了对于初创型优质企业参展的出口额要求，优质企业参展数量大幅提升。此外，通 过出台改进参展企业质量的10条举措，本届广交会指导49个地方交易团建立本地的优质企业库，优化参 展企业遴选机制，合理安排展位数量，便利更多有需要的企业获得展位。本届出口展参展企业首次超过 3万家，其中新企业超过4200家。 中国对外贸易中心副主任张思洪：本届广交会，除乡村振兴等展区、专区全免展位费外，还将对其 他出口展参展企业按50%减免展位费。调整后各展区的展位费标准在广交会官网上公布，已收取的费用 将通过各交易团、分团原路退回，确保该项举措落实到每家参展企业。 广州交易团副团长成静说，这些措施让企业得到了实惠，增强了走出去的信心。 成静：本届广交会我们共有参展企业超900家，中小企业占比超80%，本次减免优惠措施出台后， 总共减免展位费2000多万元，增强了企业"走出去"的信心。 央广网北京5月2日消息（记者黄东旭 成颖杰）据中央广播电视总台中国之声《新闻和报纸摘要》 报道，第137届广交会第三期线下展昨天（1日）开展。出台多项举措帮助外贸企业积极应对外部风险挑 战，更好服务外贸稳量提质。 第137届广交会第三期以"美 ...

中新社北京4月30日电(王梦瑶)4月30日在北京发布的《农村绿皮书：中国农村经济形势分析与预测 (2024~2025)》(下称"绿皮书")指出，2024年中国涉农工业增速全面恢复。 这份由中国社会科学院农村发展研究所与社会科学文献出版社共同发布的绿皮书指出，2024年，中国涉 农工业增加值增长4%，脱离2022年以来的低速增长区间。 食品工业方面，农副食品加工业、食品制造业以及酒饮茶业(酒、饮料和精制茶制造业的简称)增加值分 别增长2.2%、5.8%、4.8%，涨幅较上年分别提升2个、2.5个、4个百分点。 在非食品工业领域，纺织业、木材加工业、造纸业以及医药制造业的增加值分别增长5.1%、0.1%、 8.2%和3.6%，涨幅较上年分别提高5.7个、2.9个、5.1个和9.4个百分点。 绿皮书指出，2024年中国涉农工业企业营业利润总额增长2.5%，与上年相比实现扭亏为盈，也高于多 数制造业利润总额增长率，反映涉农工业发展基础坚实。 社科院研究团队认为，涉农工业增长动力主要源于出口复苏和固定资产投资增速加快。2024年，食品工 业、非食品工业出口额保持较快增长，预制菜出口企业境外营收增幅普遍超过10%。202 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 鉴于嘉兴光伏年产10GW单晶组件项目已全部转固且达到预定可使用状态，为最大程度地发挥募集资金 使用效益，提升公司经营业绩，提高对股东的回报，在扣除尚未支付的项目建设尾款等后续支出后，公 司将2019年度可转换公司债券募集资金投资项目整体节余募集资金总额4,321.97万元永久性补充流动资 金，其中包括：本次结项项目嘉兴光伏年产10GW单晶组件项目节余募集资金1,834.03万元，以及前次 已结项的银川年产15GW单晶硅棒、硅片项目扣除应付未付款项后节余募集资金668.87万元，年产5GW 单晶电池项目节余募集资金1,718.46万元和母公司账户隆基绿能节余募集资金100.61万元（截至2024年4 月30日，含累计利息净收入，具体金额以转出募集资金专户当日余额为准）。根据《上海证券交易所上 市公司自律监管指引第1号一一规范运作》规定，由于2019年度可转换公司债券募集资金投资项目节余 募集资金金额低于募集资金净额5%，公司将上述项目整体节余募集资金总额4,321.97万元永久性补充流 动资金的事项，免于履行董事会审议程序，且无需监事会、保荐机构发表明确同意意见 ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 山西焦煤(000983) 投资评级 买入 上次评级 买入 左前明 能源行业首席分析师 执业编号：S1500518070001 联系电话：010-83326712 邮 箱：zuoqianming@cindasc.com 高 升 能源、钢铁行业首席分析师 执业编号：S1500524100002 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 [Table_Title] 做优做强主业与提质增效并进，公司业绩改善可期 [Table_ReportDate] 2025 年 4 月 30 日 [Table_S 事件：2025 ummar年y]4 月 28 日 ，山西焦煤发布 2024 年年报及 2025 年一季报， 2024 年全年，公司实现营业收入 452.90 亿元，同比下降 18.43%，实现归 母净利润 31.08 亿元，同比下降 54.10%；扣非后净利润 30.15 亿元，同比 下降 55.77%。经营 ...